---
title: "Mialkos Tomasz Jakub 增持鷹瞳科技 12.67 萬股 每股作價約 12.20 港元"
description: "香港聯交所最新資料顯示，6 月 4 日，Mialkos Tomasz Jakub 增持鷹瞳科技 12.67 萬股，每股作價 12.2026 港元，總金額約為 154.61 萬港元。增持後最新持股數目為 1125.44 萬股，最新持股比例為 21.06%。"
type: "news"
locale: "zh-HK"
url: "https://longbridge.com/zh-HK/news/243463186.md"
published_at: "2025-06-06T11:11:04.000Z"
---

# Mialkos Tomasz Jakub 增持鷹瞳科技 12.67 萬股 每股作價約 12.20 港元

> 香港聯交所最新資料顯示，6 月 4 日，Mialkos Tomasz Jakub 增持鷹瞳科技 12.67 萬股，每股作價 12.2026 港元，總金額約為 154.61 萬港元。增持後最新持股數目為 1125.44 萬股，最新持股比例為 21.06%。

智通財經 APP 獲悉，香港聯交所最新資料顯示，6 月 4 日，Mialkos Tomasz Jakub 增持鷹瞳科技 (02251) 12.67 萬股，每股作價 12.2026 港元，總金額約為 154.61 萬港元。增持後最新持股數目為 1125.44 萬股，最新持股比例為 21.06%。

### Related Stocks

- [02251.HK - 鷹瞳科技-B](https://longbridge.com/zh-HK/quote/02251.HK.md)

## Related News & Research

| Title | Description | URL |
|-------|-------------|-----|
| Statutory Profit Doesn't Reflect How Good Gyldendal's (CPH:GYLD B) Earnings Are | Gyldendal A/S (CPH:GYLD B) reported strong earnings, leading to a positive stock price reaction. However, a kr.7.6m expe | [Link](https://longbridge.com/zh-HK/news/275972025.md) |
| Plan B Media Posts FY Net Profit Of 1,105 MLN Baht | Plan B Media PCL :FY NET PROFIT 1,105 MILLION BAHTFY TOTAL REVENUES 9,610 MILLION BAHTAPPROVED PAYMENT OF ANNUAL DIVIDEN | [Link](https://longbridge.com/zh-HK/news/275780046.md) |
| B Investments Studying Egp 2–3 Bln In Potential Investments Over Two Years | B INVESTMENTS HOLDING SAE :CURRENTLY STUDYING INVESTMENT OPPORTUNITIES IN RANGE OF EGP 2-3 BILLION OVER NEXT TWO YEARSIN | [Link](https://longbridge.com/zh-HK/news/275720724.md) |
| Xiaomi bought back 2.7 mln class B shares for HK$98.4 mln on Feb 13, HKEX shows | Xiaomi bought back 2.7 mln class B shares for HK$98.4 mln on Feb 13, HKEX shows | [Link](https://longbridge.com/zh-HK/news/275886566.md) |
| WHO sets out concerns over US vaccine trial in G.Bissau | The World Health Organization (WHO) has expressed serious concerns regarding a US-funded hepatitis B vaccine trial on ne | [Link](https://longbridge.com/zh-HK/news/275947546.md) |

---

> **免責聲明**：本文內容僅供參考，不構成任何投資建議。